Emerging Insights

Syndromic molecular testing has transformed infectious disease diagnostics by enabling simultaneous detection of multiple pathogens associated with a common clinical syndrome from a single specimen. However, like any diagnostic tool, syndromic testing delivers the greatest clinical value when used intentionally and in the context of pre-test probability. Diagnostic stewardship begins before the specimen is collected. The most effective testing strategy is one that aligns the patient’s symptoms, duration of illness, severity, recurrence pattern, risk factors, examination findings, and anticipated clinical management decisions with the appropriate test selection.